Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03400085
Other study ID # IRB00162212
Secondary ID K01DK114388
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date May 1, 2018
Est. completion date January 2025

Study information

Verified date January 2024
Source Johns Hopkins University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators are interested in whether or not the use of a mobile health (mHealth) application increases the rate of follow-up compliance among living kidney donors. The investigators aim to test this by randomly assigning living kidney donors to the intervention (use of mHealth application to complete required living kidney donor follow-up at 6 months, 1 year, and 2 years) or control arm (standard of care) upon discharge from their initial donation hospitalization, and tracking follow-up compliance over time. The study population will be approximately 400 living kidney donors who undergo donor nephrectomy at Methodist Specialty and Transplant Hospital (200/year for 2 years). The investigators will also recruit patients from the Vanderbilt University Medical Center into the study, however, these study participants are not a part of the Pilot Randomized Clinical Trial (RCT).


Description:

Living kidney donation has been promoted as the 'best treatment option' for eligible patients with end-stage renal disease on the transplant waitlist by the American Society of Transplantation. In 2017, 5,264 living kidney donor (LKD) transplants were performed in the United States, representing over one-third of all kidney transplants performed nationally. While living donor nephrectomy is viewed as an overall safe procedure, the surgery does carry associated potential risks, including out-of-pocket costs, difficulty obtaining insurance, and long-term health complications. In 2013, the United Network for Organ Sharing (UNOS) passed new regulations requiring transplant hospitals to collect living kidney donor (LKD) follow-up data for a minimum of 2 years post-donation. Despite this national mandate, less than 50% of transplant hospitals were able to meet reporting thresholds for LKDs who donated in 2013. Documented challenges to collecting this data include cost, donor inconvenience, and data collection burden. Therefore, novel methods are required to address incomplete donor follow-up. The investigators believe that mobile health (mHealth) systems, such as smartphone applications, would provide an effective, low-cost method of improving living donor follow-up rates. The investigators have built an mHealth system designed for reporting and collecting LKD follow-up data. The mHealth application was created based on previous studies conducted by the study team on the attitudes and perceptions of LKDs at a single transplant center on the use of mHealth for LKD follow-up, as well as after eliciting input from transplant thought leaders in the United States through semi-structured interviews. The aim of this study is to pilot test the mHealth system and compare the investigators' ability to achieve required follow-up at 6 months, 1 year, and 2 years against controls to help estimate potential effect sizes of the intervention.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 400
Est. completion date January 2025
Est. primary completion date January 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adults (=18 years) - Have undergone live donor nephrectomy at Methodist Specialty and Transplant Hospital in San Antonio, Texas - Have undergone live donor nephrectomy at Vanderbilt University Medical Center in Nashville, Tennessee Exclusion Criteria: - Participants will only be excluded if they do not consent to the study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
mHealth application
The intervention is an mHealth smartphone application designed for living kidney donors to complete their required 2-year follow-up. It allows the donor to input the answers to the clinical survey responses, as well as upload a picture of their lab values.

Locations

Country Name City State
United States Vanderbilt University Medical Center Nashville Tennessee
United States Methodist Specialty and Transplant Hospital San Antonio Texas

Sponsors (4)

Lead Sponsor Collaborator
Johns Hopkins University National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Texas Transplant Institute, Vanderbilt University Medical Center

Country where clinical trial is conducted

United States, 

References & Publications (12)

Boyarsky BJ, Massie AB, Alejo JL, Van Arendonk KJ, Wildonger S, Garonzik-Wang JM, Montgomery RA, Deshpande NA, Muzaale AD, Segev DL. Experiences obtaining insurance after live kidney donation. Am J Transplant. 2014 Sep;14(9):2168-72. doi: 10.1111/ajt.12819. Epub 2014 Jul 16. — View Citation

Fleming JN, Taber DJ, McElligott J, McGillicuddy JW, Treiber F. Mobile Health in Solid Organ Transplant: The Time Is Now. Am J Transplant. 2017 Sep;17(9):2263-2276. doi: 10.1111/ajt.14225. Epub 2017 Mar 17. — View Citation

Henderson ML, Thomas AG, Shaffer A, Massie AB, Luo X, Holscher CM, Purnell TS, Lentine KL, Segev DL. The National Landscape of Living Kidney Donor Follow-Up in the United States. Am J Transplant. 2017 Dec;17(12):3131-3140. doi: 10.1111/ajt.14356. Epub 2017 Jun 30. — View Citation

LaPointe Rudow D, Hays R, Baliga P, Cohen DJ, Cooper M, Danovitch GM, Dew MA, Gordon EJ, Mandelbrot DA, McGuire S, Milton J, Moore DR, Morgievich M, Schold JD, Segev DL, Serur D, Steiner RW, Tan JC, Waterman AD, Zavala EY, Rodrigue JR. Consensus conference on best practices in live kidney donation: recommendations to optimize education, access, and care. Am J Transplant. 2015 Apr;15(4):914-22. doi: 10.1111/ajt.13173. Epub 2015 Feb 3. — View Citation

Mandelbrot DA, Pavlakis M, Karp SJ, Johnson SR, Hanto DW, Rodrigue JR. Practices and barriers in long-term living kidney donor follow-up: a survey of U.S. transplant centers. Transplantation. 2009 Oct 15;88(7):855-60. doi: 10.1097/TP.0b013e3181b6dfb9. — View Citation

Mandelbrot DA, Pavlakis M. Living donor practices in the United States. Adv Chronic Kidney Dis. 2012 Jul;19(4):212-9. doi: 10.1053/j.ackd.2012.04.010. — View Citation

Ommen ES, LaPointe Rudow D, Medapalli RK, Schroppel B, Murphy B. When good intentions are not enough: obtaining follow-up data in living kidney donors. Am J Transplant. 2011 Dec;11(12):2575-81. doi: 10.1111/j.1600-6143.2011.03815.x. Epub 2011 Nov 4. — View Citation

OPTN Policy 18 Living Donor Data Submission Requirements. 2016: 220.

Organ Procurement and Transplantation Network. National Data 2017.

Rodrigue JR, Schold JD, Morrissey P, Whiting J, Vella J, Kayler LK, Katz D, Jones J, Kaplan B, Fleishman A, Pavlakis M, Mandelbrot DA; KDOC Study Group. Predonation Direct and Indirect Costs Incurred by Adults Who Donated a Kidney: Findings From the KDOC Study. Am J Transplant. 2015 Sep;15(9):2387-93. doi: 10.1111/ajt.13286. Epub 2015 May 5. — View Citation

Segev DL, Muzaale AD, Caffo BS, Mehta SH, Singer AL, Taranto SE, McBride MA, Montgomery RA. Perioperative mortality and long-term survival following live kidney donation. JAMA. 2010 Mar 10;303(10):959-66. doi: 10.1001/jama.2010.237. — View Citation

Waterman AD, Dew MA, Davis CL, McCabe M, Wainright JL, Forland CL, Bolton L, Cooper M. Living-donor follow-up attitudes and practices in U.S. kidney and liver donor programs. Transplantation. 2013 Mar 27;95(6):883-8. doi: 10.1097/TP.0b013e31828279fd. — View Citation

* Note: There are 12 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary 6-month compliance to follow-up Compliance with submitting questionnaires and laboratory values within 60 days of the six-month donation anniversary. Participants in the intervention arm will receive notifications when their follow-up is available to complete via the mHealth app, and subsequent notifications thereafter until either the donor completes both clinical and laboratory components of the required follow-up, or they are no longer compliant and within the 60-day window. Participants in the control arm will complete their follow-up as is current standard of care at Texas Transplant Institute. 6 months
Primary 1-year compliance to follow-up Compliance with submitting questionnaires and laboratory values within 60 days of the 1-year donation anniversary. Participants in the intervention arm will receive notifications when their follow-up is available to complete via the mHealth app, and subsequent notifications thereafter until either the donor completes both clinical and laboratory components of the required follow-up, or they are no longer compliant and within the 60-day window. Participants in the control arm will complete their follow-up as is current standard of care at Texas Transplant Institute. 1 year
Primary 2-year compliance to follow-up Compliance with submitting questionnaires and laboratory values within 60 days of the 2-year donation anniversary. Participants in the intervention arm will receive notifications when their follow-up is available to complete via the mHealth app, and subsequent notifications thereafter until either the donor completes both clinical and laboratory components of the required follow-up, or they are no longer compliant and within the 60-day window. Participants in the control arm will complete their follow-up as is current standard of care at Texas Transplant Institute. 2 years
Secondary 6-month center follow-up compliance Overall center rate of compliance with follow-up with 80% of all donors within 60 days of the six-month donation anniversary. 6 months
Secondary 1-year center follow-up compliance Overall center rate of compliance with follow-up with 80% of all donors within 60 days of the 1-year donation anniversary. 1 year
Secondary 2-year center follow-up compliance Overall center rate of compliance with follow-up with 80% of all donors within 60 days of the 2-year donation anniversary. 2 years
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT03691935 - Erector Spinae Plane Block (ESPB): in Patients Undergoing Surgery Through a Flank or Anterior Subcostal Incision. Phase 4
Recruiting NCT01093079 - Laparoscopic Versus Open Partial Nephrectomy - Surgical and Oncological Outcomes N/A
Recruiting NCT04546230 - Low-Thoracic Epidural Anesthesia For Laparoscopic Nephrectomy. N/A
Completed NCT05596669 - Analgesic Effect of Ketamine Vs Ketamine Magnesium Infusion and Their Effect on Postoperative Morphine Consumption Phase 1
Enrolling by invitation NCT02287987 - CLamp vs Off Clamp Kidney During Partial Nephrectomy N/A
Terminated NCT01008709 - Comparison Study of Two Different Surgical Clips During Laparoscopic Urologic Surgery N/A
Completed NCT00765232 - Intravenous Ketorolac for Postoperative Pain in Laparoscopic Donor Nephrectomy Phase 4
Completed NCT03155295 - Simulated Surgery Rehearsal (MIPN)
Completed NCT04402749 - The Incidence of Pulmonary Embolism During Nephrectomy
Completed NCT01236326 - Conventional Laparoscopic Versus Laparoendoscopic Single Site Donor Nephrectomy in Living Donor Kidney Transplantation N/A
Completed NCT06119568 - Safety and Performance Assessment of a First Four Arms on Demand Open Robotic Solution for Assisted PN, RN and RP N/A
Completed NCT03324490 - Thoracic Spinal Versus Epidural Anesthesia for Nephrectomy in Obstructive/Restrictive Lung Disease Patients N/A
Not yet recruiting NCT06256120 - Effect of Fluid Regimen on Acute Kidney Injury N/A
Completed NCT03581539 - Comparing 3 Different Types of Pain Blocks After Laparoscopic Nephrectomy N/A
Completed NCT03428633 - Thoracic Paravertebral Blocks in Open Nephrectomy Phase 2
Active, not recruiting NCT03090646 - Use of Financial Incentives to Increase Live Kidney Donor Follow-up Compliance N/A
Not yet recruiting NCT05106218 - Assessment of the SurroundScope in Urologic Surgical Procedures N/A
Completed NCT01054469 - Transversus Abdominus Plane Block N/A
Not yet recruiting NCT05149196 - Goal-directed Hemodynamic Management and Kidney Injury After Radical Nephrectomy N/A
Recruiting NCT04404738 - MicroPort® Endoscopic Instrument Control System to Accomplish Robotic-assisted Surgery in Urology N/A